Tocilizumab ( Actemra By Roche ) Significantly Decreased Mortality in COVID19 Patients With No Increased Discharge, Secondary Infection Risk, Adverse Events, And Mechanical Ventilation in Meta-Analysis .

Efficacy And Safety Of Tocilizumab Treatment COVID-19 Patients : A Case-Control Study And Meta-Analysis .

... Nuestros Datos Sugieren Que los Médicos Deben Prestar Atención a la Terapia con Tocilizumab Como un Tratamiento Eficaz y Seguro Para los Pacientes con COVID19 . ...